Antipsychotic drug risperidone effective in treating autistic children

NewsGuard 100/100 Score

In a study sponsored by the U.S. National Institute of Mental Health, and conducted over a number of sites, it has been found that the antipsychotic drug risperidone is a safe, effective treatment for children with autism who display tantrums, aggression and often self-injure.

Of the 101 children, 82 boys, and 19 girls, aged 5 to 17, in the study, it was found that treatment with risperidone resulted in decreased aggression, reduced repetitive behaviors and increased social interaction, and there were also limited side effects.

The study also found when the risperidone was discontinued after six months of treatment, a rapid return of aggressive and disruptive behavior was seen in most cases.

Dr. James McCracken, of the Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles, and the study author, says a variety of treatments, including medication, are often used to manage aggressive behaviors in autistic children, but controlled medication trials are limited.

He says their findings support the addition of risperidone to the small arsenal of intermediate-term medication options for the tens of thousands of children with autism who display aggressive and destructive behavior.

He says that the response to risperidone ranks among the most positive for a drug treatment ever observed in children with autism.

The findings appear in the July issue of the American Journal of Psychiatry.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Maternal diabetes linked to a slight increase in ADHD risk in children